Blanver Farmoquimica Ltda.

About Blanver Farmoquimica Ltda.

Blanver is a Brazilian company, founded in 1984, which develops, manufactures and commercializes medicines and active pharmaceutical ingredients (APIs). In medicines, we develop and manufacture high quality products in the HIV, Hepatitis and Osteoporosis segments, serving patients in Brazil through partnerships with the Ministry of Health and official laboratories. In APIs, we are increasing our production and development capacity of products in the HIV and Bipolar Disorder segments.

Part of our strategy is to expand our presence in the international market through partnerships to export our medicines and APIs.

Blanver is also looking for strategic alliances with international partners of recognized quality, to license and commercialize innovative and established products in segments such as oncology and hematology in Brazil and Latin America.

We operate in the state of São Paulo, with two production plants – one in the city of Taboão da Serra, where our medicines are manufactured, and the other in Ind...

  • BR
  • 2015
    On CPHI since
  • 1
  • 250 - 499
Company types
Contact info

Products from Blanver Farmoquimica Ltda. (3)

  • Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg

    Product Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg

    - Presentation: Plastic bottles with 30 coated tablets.  

    - Indication (Brazil Prescription Medicines): 
    1) For PrEP® (pre-exposure prophylaxis), it can help reduce the risk of getting HIV-1 through sex, when taken every day and used together with safer sex practices.
    2) ...
  • Raloxifene Hydrochloride 60 mg

    Product Raloxifene Hydrochloride 60 mg

    - Presentation: Blisters containing 28 film-coated tablets  

    - Indication (Brazil Prescription Medicines): 
    1) For the prevention and treatment of osteoporosis;
    2) To reduce the risk of breast cancer in postmenopausal womem with osteoporosis.

    - Re...
  • Tenofovir Disoproxil Fumarate

    Product Tenofovir Disoproxil Fumarate

    API - Active Pharmaceutical Ingredient

    - Therapeutic Area: HIV infection and Chronic Hepatitis B
    - Status: DMF (Drug Master File Ready) 

    Blanver fully respects the patents’ expiration dates in all countries

Blanver Farmoquimica Ltda. Resources (1)